节点文献

共表达甲状腺转录因子1与p40的非小细胞肺癌患者临床病理特征分析

Clinicopathological Features of Non-small Cell Lung Carcinoma with Coexpression of Thyroid Transcription Factor-1 and p40

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 陈慧萍; 张瑞珍; 章纳; 任景丽; 冯怡锟; 胡桂明;

【Author】 CHEN Huiping;ZHANG Ruizhen;ZHANG Na;REN Jingli;FENG Yikun;HU Guiming;Pathology Department,Women and Infants Hospital of Zhengzhou;Pathology Department,the Second Affiliated Hospital of Zhengzhou University;

【通讯作者】 胡桂明;

【机构】 郑州市妇幼保健院病理科; 郑州大学第二附属医院病理科;

【摘要】 目的 探讨共表达甲状腺转录因子1(TTF-1)和p40的非小细胞肺癌(NSCLC)患者的临床病理特征。方法 收集7例共表达TTF-1和p40的NSCLC患者的资料,回顾性分析其临床特征、病理形态、免疫表型及分子特征,并复习相关文献。结果 患者中位年龄58岁,多为男性且吸烟者;影像显示为外周型肿块。肿瘤细胞呈实性巢状排列,瘤细胞呈圆形、卵圆形或多角形,胞质透明或嗜酸性,核分裂象>10个/10HPF;3例可见脉管内癌栓。同一群肿瘤细胞同时表达TTF-1和p40,CK7、p63、CK5/6和napsinA呈灶性或弥漫表达,增殖指数Ki-67阳性10%~90%。2例采用ARMS-PCR法分别检测到表皮生长因子受体(EGFR) 18号外显子G719A/S/C突变和21号外显子L858R突变,1例采用二代测序法检测到TPM3-ROS1融合突变和ROS1(G2032R)突变。随访1~46个月,2例患者分别于22、46个月死亡,3例患者出现颈部淋巴结或脑转移。结论 共表达TTF-1和p40的NSCLC具有独特的临床病理特征,临床进展快,预后差,可能是一种新的肿瘤实体。

【Abstract】 Objective To explore the clinical and pathological characteristics of non-small cell lung carcinoma(NSCLC) patients with co-expressing thyroid transcription factor-1(TTF-1) and p40.Methods Seven cases of NSCLC co-expressing TTF-1 and p40 were collected. A retrospective analysis of their clinical features, pathological morphology, immunophenotype, and molecular characteristics was conducted, along with a review of relevant literature.Results The patients with a median age of 58 years old, common in males or people who had a history of smoking. Imaging showed peripheral masses in all cases. Tumor cells exhibited a solid nest-like arrangement, round, oval, or polygonal, with transparent or acidophilic cytoplasm; the mitotic figures were >10/10 high-power fields(HPF). Vascular tumor emboli were observed in 3 cases. The same group of tumor cells expressed TTF-1 and p40 simultaneously; CK7, p63, CK5/6 and napsinA showed focal or diffuse expression, and the Ki-67 proliferative index was positive in 10% to 90%. According to g ARMS-PCR, two cases were found to have epidermal growth factor receptor(EGFR) exon 18 G719A/S/C mutations and exon 21 L858R mutations, while using next-generation sequencing, one case showed TPM3-ROS1 fusion mutation and ROS1(G2032R) mutation. After 1 to 46 months of followed-up, two patients died after 22 and 38 months, respectively. Three patients developed cervical lymph node or brain metastasis.Conclusion NSCLC co-expressing TTF-1 and p40 exhibits unique clinical and pathological features, characterized by rapid clinical progression and poor prognosis, suggesting it may represent a novel tumor entity.

【基金】 河南省医学科技攻关计划联合共建项目(LHGJ20230364)
  • 【文献出处】 河南医学研究 ,Henan Medical Research , 编辑部邮箱 ,2024年19期
  • 【分类号】R734.2
  • 【下载频次】3
节点文献中: 

本文链接的文献网络图示:

本文的引文网络